While complement-dependent cytotoxicity (CDC) is a known effector mechanism in
aquaporin-4-immunoglobulin (Ig) G-positive (AQP4-IgG+) neuromyelitis optica spectrum …

Background and Objectives The objective was to study complement-mediated cytotoxicity
induced by immunoglobulin G (IgG) anti–aquaporin-4 antibodies (AQP4-IgG) and anti …

Background and Objective Neuromyelitis optica spectrum disorders (NMOSD) and myelin
oligodendrocyte glycoprotein antibody (MOG-IgG) associated disease (MOGAD) are …

Background Neuromyelitis optica spectrum disorder (NMOSD) refers to a range of
autoimmune inflammatory demyelinating diseases affecting the optic nerves, spinal cord …

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disease of
the central nervous system. Most NMOSD patients are seropositive for immunoglobulin G …

Immunoglobulin G against myelin oligodendrocyte glycoprotein (MOG-IgG) is detectable in
neuromyelitis optica spectrum disorder (NMOSD) without aquaporin-4 IgG (AQP4-IgG), but …

Background Serum autoantibodies against the water channel aquaporin-4 (AQP4) are
important diagnostic biomarkers and pathogenic factors for neuromyelitis optica (NMO) …

Objective To elucidate the differences in the source and in the level of intrathecal synthesis
between anti–aquaporin-4 antibodies (AQP4-IgG) and anti-myelin oligodendrocyte …

Objective To investigate whether aquaporin-4–immunoglobulin G (AQP4-IgG) titers and
measures of complement-mediated cell killing are clinically useful to predict the occurrence …

Objective To evaluate cerebrospinal fluid (CSF) cytokine profiles in myelin oligodendrocyte
glycoprotein IgG-positive (MOG-IgG+) disease in adult and paediatric patients. Methods In …